Session(s)
- Measuring the Functional Impact of Pulmonary Arterial Hypertension with Actigraphy [Board ...
Sunday, May 20 9:15 AM - 11:15 AM - Sleep Disordered Breathing in Patients with Pulmonary Arterial Hypertension and Impact of ...
Sunday, May 20 11:15 AM - 1:00 PM - Medical Therapy and Future Perspectives in CTEPH
Sunday, May 20 3:55 PM - 4:15 PM - Hughes-Stovin Syndrome and Chronic Thromboembolic Pulmonary Hypertension: A Case Report [B...
Monday, May 21 11:15 AM - 1:00 PM - CTEPH: MEDICINE, SURGERY OR ANGIOPLASTY?
Monday, May 21 12:15 PM - 1:15 PM - Regional Vascular Transit Times in the Human Lung: A Potential New Noninvasive Biomarker f...
Monday, May 21 2:15 PM - 4:15 PM - The Pulmonary Blood Flow Distribution Measured with MRI Shows Large Regions with Undetecta...
Monday, May 21 2:15 PM - 4:15 PM - Baseline and Demographic Data on the First 250 Patients from SPHERE (UptraviĀ® [SelexiPag]:...
Tuesday, May 22 11:15 AM - 1:00 PM - Patient Characteristics and Treatment Patterns in the Largest Real-World Cohort of Pulmona...
Tuesday, May 22 11:15 AM - 1:00 PM - Transitions from Inhaled, Intravenous, Subcutaneous, or Oral Prostacyclins to Selexipag: I...
Tuesday, May 22 11:15 AM - 1:00 PM - Moderator
Wednesday, May 23 9:15 AM - 11:15 AM - A CTEPH Mimic: In Situ Clot in Severe Pulmonary Hypertension [Board No. P445]
Wednesday, May 23 11:15 AM - 1:00 PM - Real-World Dosing and Titration of Selexipag in Patients with Pulmonary Arterial Hypertens...
Wednesday, May 23 1:30 PM - 3:30 PM